SEER Inquiry System - Question 20051095 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 10/28/2025 11:33 PM

Question 20051095

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

SEER*Rx

Question:

Chemotherapy/Immunotherapy: How do we code Rituxan for Non-Hodgkin Lymphoma and Herceptin for breast cancer? See Discussion.

Discussion:

Page 195 of the SEER Manual 2004 lists these as examples of Immunotherapy. The new SEER*Rx categorizes these as chemotherapy.

(Sinq # 20041025 says to code Avastin and Erbitux as chemotherapy, too.)

Answer:

Code Rituxan and Herceptin as chemotherapy.

SEER*Rx is effective for cases diagnosed 1-1-2005 and forward. It replaces all previous references. Be sure to use SEER*Rx [http://seer.cancer.gov/tools/seerrx/]

because some agents changed categories when SEER*Rx was deployed.

It is neither required nor recommended that cases treated prior to 2005 be recoded.

Cancer Site Category:

N/A

Data Item Category:

Chemotherapy, Immunotherapy

Other Category:

N/A

Year:

2005